Search results
Liver Resection Improves Survival in Early Multinodular HCC
Medscape· 2 days agoA large analysis demonstrated longer 3- and 5-year survival rates in patients with early...
American International Group Inc. Reduces Position in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 5 days agoAmerican International Group Inc. trimmed its holdings in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 6.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned ...
Updates from the 2022 WHO classification of kidney epithelial tumors
Medical Xpress· 4 days agoThe World Health Organization (WHO) and the International Society of Urologic Pathology (ISUP) have...
Three Japanese Exchange Growth Companies With High Insider Ownership And 15% Earnings Growth
Simply Wall St. via Yahoo Finance· 5 days agoAmidst a backdrop of mixed performance in global markets, Japan's stock markets have shown...
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is Perceptive Advisors LLC’s 10th Largest Position
ETF DAILY NEWS· 6 days agoPerceptive Advisors LLC lifted its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.1% during the 4th quarter, HoldingsChannel reports. The institutional ...
Weight Loss is Associated with Decreased Cancer Risk in Individuals with Obesity
The Arab Tribune· 20 hours agoToday, data from a retrospective observational study conducted using the electronic health record at the Cleveland Clinic, shows that real-world weight loss can be associated with a reduced ...
Sivia Capital Partners LLC Invests $226,000 in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 4 days agoSivia Capital Partners LLC bought a new stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 9,436 shares of the biotechnology ...
Chicago Partners Investment Group LLC Grows Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
ETF DAILY NEWS· 4 days agoChicago Partners Investment Group LLC raised its holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 15.0% during the 4th quarter, HoldingsChannel.com reports. The fund ...